Sign in

CIK 0001762303

  • Non-accelerated filer
  • Smaller reporting company

AVITA Medical, Inc.

Sign in to watch
Tickers
RCEL AVHHL
Exchange
Nasdaq, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202578762
Phone
+1 661-568-1317
Business address
28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
Former names
Avita Therapeutics, Inc., Avita Medical, Ltd.

Securities

  • RCEL Common Stock Nasdaq
  • AVHHL Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-20 Crowe Suzanne Director Grant or award +22,214 69,148
2026-01-20 Crowe Suzanne Director Grant or award · Stock Options (Right to Buy) +16,133 16,133
2025-01-21 Crowe Suzanne Director Grant or award +10,022 46,934
2025-01-21 Crowe Suzanne Director Grant or award · Stock Options (Right to Buy) +4,295 4,295
2024-12-09 Crowe Suzanne Director Purchase +486 $13.15 $6K 36,912
2024-06-05 Crowe Suzanne Director Grant or award +9,200 36,426
2024-06-05 Crowe Suzanne Director Grant or award · Stock Options (Right to Buy) +3,943 3,943
2023-06-06 Crowe Suzanne Director Grant or award +6,175 27,226
2023-06-06 Crowe Suzanne Director Grant or award · Stock Options (Right to Buy) +2,646 2,646
2022-12-12 Crowe Suzanne Director Grant or award +12,589 21,051
2022-12-12 Crowe Suzanne Director Grant or award · Stock Options (Right to Buy) +5,395 5,395
2021-12-22 Crowe Suzanne Director Grant or award +4,350 8,462
2021-12-22 Crowe Suzanne Director Grant or award · Stock Options (Right to Buy) +2,550 2,550
2021-09-20 Crowe Suzanne Director Purchase +1,066 $17.08 $18K 4,112

Page 1 of 1 · 14 trades